Bacterial lipopolysaccharide activates HIV long terminal repeat through Toll-like receptor 4

Journal of Immunology

Volumn 166, Issue 4, 2001, Pages 2342-2347

  Equils, O ^a   Faure, E ^a   Thomas, L ^a   Bulut, Y ^a   Trushin, S ^a   Arditi, M ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CELL SURFACE RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; LUCIFERASE; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR 4; VIRUS RNA;

ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUPERINFECTION; TRANSACTIVATION; VIRUS ACTIVATION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

EID: 0035865198     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.4.2342     Document Type: Article

References (79)

1. Current understanding of sepsis
2. Bacterial endotoxin: Chemical constitution, biological recognition, host response, and immunological detoxification
3. Inhibitory effect of growth hormone on TNF-α secretion and nuclear factor-κB translocation in lipopolysaccharide-stimulated human monocytes
4. Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-Rel and related NF-κB proteins in human monocytic THP-1 cells
5. Cell-free pool of CD14 mediates activation of transcription factor NF-κB by lipopolysaccharide in human endothelial cells
6. NF-κB: Ten years after
7. Pro-inflammatory signaling: Last pieces in the NF-κB puzzle?
8. The Toll-receptor family and control of innate immunity
9. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults
10. Tlr4: Central component of the sole mammalian LPS sensor
11. Bacterial lipopolysaccharide activates nuclear factor-κB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes
12. Intracellular factors involved in gene expression of human retroviruses
13. An inducible transcription factor activates expression of human immunodeficiency virus in T cells
14. Cytokine modulation of HIV expression
15. Host factors and the pathogenesis of HIV-induced disease
16. Activation of human immunodeficiency virus by herpes simplex virus
17. The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults
18. Bidirectional interactions between human immunodeficiency virus type 1 and cytomegalovirus
19. Immune stimulation and HIV-1 viral replication
20. Effect of coinfection with STDs and of STD treatment on HIV shedding in genital-tract secretions: Systematic review and data synthesis
21. HMEC-1: Establishment of an immortalized human microvascular endothelial cell line
22. Chemical, physical, biological properties of a lipopolysaccharide from Escherichia coli K-235
23. RAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling
24. The human Toll signaling pathway: Divergence of nuclear factor κB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6)
25. Tumor necrosis factor (TNF)-mediated kinase cascades: Bifurcation of nuclear factor-κB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2
26. HIV enhancer activity perpetuated by NF-κB induction on infection of monocytes
27. Tumor necrosis factor α activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-κB sites in the long terminal repeat
28. Bacterial lipopolysaccharide activates NF-κB through Toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells: Differential expression of tlr-4 and tlr-2 in endothelial cells
29. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of 1κB kinase
30. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4)
31. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene
32. n gene: In vivo evidence for a dominant negative mutation
33. Cloning and characterization of two Toll/interleukin-1 receptor-like genes TIL3 and TIL4: Evidence for a multi-gene receptor family in humans
34. Amino acids conserved in interleukin-1 receptors (IL-1Rs) and the Drosophila Toll protein are essential for IL-1R signal transduction
35. A family of human receptors structurally related to Drosophila Toll
36. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
37. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB
38. IKK-1 and IKK-2: Cytokine-activated IκB kinases essential for NF-κB activation
39. IκB kinase-β: NF-κB activation and complex formation with IκB kinase-α and NIK
40. A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκB-α that is still bound to NF-κB
41. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
42. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
43. The PPARα-leukotriene B4 pathway to inflammation control
44. Convergence of 9-cis retinoic acid and peroxisome proliferator signaling pathways through heterodimer formation of their receptors
45. 2 in activated murine macrophages
46. Activation of phosphatidylinositol 3-kinase, protein kinase B, and p70 S6 kinases in lipopolysaccharide-stimulated raw 264.7 cells: Differential effects of rapamycin, LY294002, and wortmannin on nitric oxide production
47. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-κB p65/RelA subunit
48. Phosphatidylinositol 3-kinase as a mediator of TNF-induced NF-κB activation
49. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells
50. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine
51. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
52. Bicyclic imidazoles as a novel class of cytokine biosynthesis inhibitors
53. The critical role of p38 MAP kinase in T cell HIV-1 replication
54. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-κB p65 transactivation mediated by tumor necrosis factor
55. Activation of the HIV-1 long terminal repeat by cytokines and environmental stress requires an active CSBP/p38 MAP kinase
56. Both PU.1 and nuclear factor-κB mediate lipopolysaccharide-induced HIV-1 long terminal repeat transcription in macrophages
57. HIV-1 auxiliary proteins: Making connections in a dying cell
58. Cellular transcription factors involved in the regulation of HIV-1 gene expression
59. Regulation of HIV-1 gene expression
60. Activation of HIV gene expression during monocyte differentiation by induction of NF-κB
61. Tumor necrosis factor α and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor κB
62. How NF-κB is activated: The role of the IκB kinase (IKK) complex
63. Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression
64. CD14 is involved in control of human immunodeficiency virus type 1 expression in latently infected cells by lipopolysaccharide
65. Cytokine augmentation of HIV-LTR-driven gene expression in neural cells
66. High levels of tumor necrosis factor-α and interleukin-1β in bacterial vaginosis may increase susceptibility to human immunodeficiency virus
67. Activation of human monocyte-derived macrophages with lipopolysaccharide decreases human immunodeficiency virus replication in vitro at the level of gene expression
68. Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro
69. C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells
70. LPS-inducible nuclear factor in human monocytes that binds the negative regulatory element of the HIV LTR
71. Differential expression and regulation of Toll-like receptors (TLR) in human leukocytes: Selective expression of TLR3 in dendritic cells
72. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties
73. Induction of TH1 and TH2 responses: A key role for the 'natural' immune response?
74. Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon γ production and diminishes interleukin 4 inhibition of such priming
75. + T-helper 1 (Th1)- and Th2-type conditions
76. + T lymphocytes: R5 but not X4 viruses replicate in the absence of T-cell receptor restimulation
77. Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages
78. Lipopolysaccharide-induced selective priming effects on tumor necrosis factor α and nitric oxide production in mouse peritoneal macrophages
79. Reprogramming of lipopolysaccharide-primed macrophages is controlled by a counterbalanced production of IL-10 and IL-12